Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma

Archive ouverte

Plissonnier, Marie-Laure | Herzog, Katharina | Levrero, Massimo | Zeisel, Mirjam, B

Edité par CCSD ; MDPI -

International audience. Hepatitis C virus (HCV) infection is a worldwide health problem and is one of the main causes of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). Despite recent improvements, effective treatments for HCC are still missing and new tools for early detection are needed. Non-coding RNAs (ncRNAs) have emerged as important regulators of gene expression and key players in human carcinogenesis, including HCC. Aberrant expression of ncRNAs is associated with HCC metastasis, invasion, dissemination, and recurrence. This review will focus on the recent advances in ncRNA expression profiles, their dysregulation in HCV-related HCC, and the clinical perspective of ncRNA signatures for the early detection of HCC.

Suggestions

Du même auteur

miR-122-regulated metabolic circuits: micro-management of lipid metabolism in the human liver

Archive ouverte | Zeisel, Mirjam, B. | CCSD

International audience

Hépatite C, EGFR, cirrhose et nétrine-1: Intérêt en hépatocarcinogenèse ?

Archive ouverte | Plissonnier, Marie-Laure | CCSD

International audience

The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL.

Archive ouverte | Plissonnier, Marie-Laure | CCSD

International audience. BACKGROUND: Ciglitazone belongs to the thiazolidinediones class of antidiabetic drug family and is a high-affinity ligand for the Peroxisome Proliferator-Activated Receptor γ (PPARγ). Apart f...

Chargement des enrichissements...